Factors within the TME, like hepatocyte growth factor (HGF), which binds to the c-MET tyrosine kinase receptor activating β-catenin-dependent transcription, support CSC phenotypes and contribute to tumor heterogeneity by providing suitable niches for CSCs [80]. The gene discussed is HGF; the disease is neoplasm.